PDE4 inhibitor rolipram represses hedgehog signaling via ubiquitin-mediated proteolysis of GLI transcription factors to regress breast cancer
Journal of Biological Chemistry · 2025-03 · 301 (3) · 108239
DOI: 10.1016/j.jbc.2025.108239 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2025-03. Verfasst von Arka Bagchi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Cell and Molecular Biology Laboratory, Department of Zoology, University of Kalyani, Nadia, West Bengal, India. Hauptthemen laut MEDLINE: Hedgehog Proteins, Signal Transduction, Breast Neoplasms, Proteolysis. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Government of West Bengal Department of Science and Technology.
Abstract (Originalsprache)
Aberrant activation of the Hedgehog (Hh) signaling pathway positively correlates with progression, invasion, and metastasis of several cancers, including breast cancer. Although numerous inhibitors of the Hh signaling pathway are available, several oncogenic mutations of key components of the pathway, including Smoothened, have limited their capability to be developed as putative anticancer drugs. In this study, we have modulated the Hh signaling pathway in breast cancer using a specific Food and Drug Administration-approved phosphodiesterase 4 inhibitor rolipram. The results indicated that increased levels of cAMP-dependent PKA, because of the treatment with rolipram on MCF-7 and MDA-MB-231 cells, induced PKA-mediated ubiquitination of glioma-associated oncogene homolog 2 full length (GLI2FL) and GLI3FL, leading to their transformation to respective repressor forms. This in turn reduced the level of GLI1 (glioma-associated oncogene homolog 1) transcription factor in a time-dependent manner. We have also shown that elevated levels of PKA reduced the level of phosphorylated glycogen synthase kinase 3β, which is known to augment PKA-mediated ubiquitination of GLI2FL and GLI3FL. Rolipram treatment also impaired wound healing and migration in both cell lines and significantly reduced tumor weight and volume in tumor-bearing mice. Histological analysis showed a reduction in multinucleated cells and cellular infiltration in the lungs of rolipram-treated mice. Moreover, rolipram decreased GLI1 levels in tumors by enhancing cAMP-PKA signaling. These findings suggest that rolipram effectively inhibits the Hh pathway downstream of Smoothened, offering potential as a therapeutic strategy for controlling breast cancer progression and metastasis, including both hormone-responsive and triple-negative subtypes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cell and Molecular Biology Laboratory, Department of Zoology, University of Kalyani, Nadia, West Bengal, India.
- Cancer Research Laboratory, Department of Zoology, University of Calcutta, Kolkata, West Bengal, India.
- Cancer Research Laboratory, Department of Zoology, University of Calcutta, Kolkata, West Bengal, India. Electronic address: urmichatterji@gmail.com.
- Cell and Molecular Biology Laboratory, Department of Zoology, University of Kalyani, Nadia, West Bengal, India. Electronic address: arunima10@gmail.com.
Förderung
- Government of West Bengal Department of Science and Technology
Zitieren
APA
Bagchi, A., Bhattacharya, A., Bera, A., Basak, D., Chatterji, U., & Biswas, A. (2025). PDE4 inhibitor rolipram represses hedgehog signaling via ubiquitin-mediated proteolysis of GLI transcription factors to regress breast cancer. Journal of Biological Chemistry, 301(3), 108239. https://doi.org/10.1016/j.jbc.2025.108239
Vancouver
Bagchi A, Bhattacharya A, Bera A, Basak D, Chatterji U, Biswas A. PDE4 inhibitor rolipram represses hedgehog signaling via ubiquitin-mediated proteolysis of GLI transcription factors to regress breast cancer. Journal of Biological Chemistry. 2025;301(3):108239. doi:10.1016/j.jbc.2025.108239
BibTeX
@article{Bagchi2025,
author = {Bagchi, Arka and Bhattacharya, Anuran and Bera, Analava and Basak, Deblina and Chatterji, Urmi and Biswas, Arunima},
title = {PDE4 inhibitor rolipram represses hedgehog signaling via ubiquitin-mediated proteolysis of GLI transcription factors to regress breast cancer},
journal = {Journal of Biological Chemistry},
year = {2025},
volume = {301},
number = {3},
pages = {108239},
doi = {10.1016/j.jbc.2025.108239}
}
EUVIMED